Arzeda logo

Arzeda

arzeda.com

Arzeda designs novel proteins and enzymes using AI-driven computational methods, delivering BioSolutions for industries such as food and nutrition, home and personal care, advanced materials, and pharmaceuticals. Its products aim to improve customer products and manufacturing processes while reducing environmental impact.

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Type
Corporation Seattle business license
Employees
79
Registered name
Arzeda Corp Seattle business license
Members see funding amounts.
.
Founders
Alexandre Zanghellini, David Baker

Is this your organization? Claim it

Life Science Washington, Arzeda Host NSCEB Commissioners in Seattle to Press for $15B Federal Boost and Policy Changes to Shore Up U.S. Biotech Competitiveness

Life Science Washington and Arzeda hosted NSCEB commissioners in Seattle to showcase the region’s biotech strengths and discuss federal policy, emphasizing needs for research funding, capital access, scale-up capacity, AI-enabled infrastructure, and workforce development to bolster U.S. biotech competitiveness against China.

TerraPower Isotopes’ Chris Dunckley Leads Team Extracting Ultra-Rare Actinium-225 from Cold War Waste for Cancer Therapy

Chris Dunckley, director of chemistry and engineering at TerraPower Isotopes, leads a multidisciplinary team extracting the ultra-rare radioisotope actinium-225 from Cold War nuclear waste to develop promising cancer therapies. His leadership and scientific expertise help transform radioactive weapons waste into potentially life-saving medical treatments.

See all 9 stories, episodes and videos about Arzeda.

People

See all 5
  • Alex Zanghelini Co-founder
  • Alexandre Zanghellini
    Alexandre Zanghellini Executive Officer, Director, Promoter, Co-founder and PhD — Co-Founder & Chief Executive Officer
  • Ken Barrett Executive, MBA, MS — Chief Business Officer

Online